SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-004469
Filing Date
2021-06-22
Accepted
2021-06-22 16:15:19
Documents
14
Period of Report
2021-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062121.htm   iXBRL 8-K 38125
2 EXHIBIT 99.1 exh_991.htm EX-99.1 159020
3 EXHIBIT 99.2 exh_992.htm EX-99.2 52242
  Complete submission text file 0001171843-21-004469.txt   474528

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE anik-20210616.xsd EX-101.SCH 2732
5 XBRL LABEL FILE anik-20210616_lab.xml EX-101.LAB 35273
6 XBRL PRESENTATION FILE anik-20210616_pre.xml EX-101.PRE 23130
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_062121_htm.xml XML 3492
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 211035531
SIC: 3841 Surgical & Medical Instruments & Apparatus